HK1 and cancer: While increased expression of glucose transporter and glycolytic enzymes during cellular senescence was observed, to date relevant data mostly derived from cancers such as lymphomas and melanomas, or senescent cells induced by activation of oncogenes (OIS) such as BRAFV600E, with the metabolic signaling axis specifically elucidated in senescent cancer cells19,20.